CUSIP: G6461G106
Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
66,428,329
-
Share change
-
+6,295,413
-
Total reported value
-
$750,588,000
-
Price per share
-
$11.30
-
Number of holders
-
41
-
Value change
-
+$82,342,858
-
Number of buys
-
25
-
Number of sells
-
15
Quarterly Holders Quick Answers
What is CUSIP G6461G106?
CUSIP G6461G106 identifies NFH - NEW FRONTIER HEALTH CORP - ORD SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2021
-
Previous quarter:
Q4 2020
Recent filing periods for CUSIP G6461G106:
Institutional Holders of NEW FRONTIER HEALTH CORP - ORD SHS (NFH) as of Q1 2021
As of 31 Mar 2021,
NEW FRONTIER HEALTH CORP - ORD SHS (NFH) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,428,329 shares.
The largest 10 holders included
Vivo Capital, LLC, Capital Research Global Investors, Fosun International Ltd, Aspex Management (HK) Ltd, MORGAN STANLEY, Oasis Management Co Ltd., WELLINGTON MANAGEMENT GROUP LLP, BAMCO INC /NY/, York Capital Management Global Advisors, LLC, and Yiheng Capital Management, L.P..
This page lists
41
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.